This inventor holds 1 USPTO granted patent. Top assignee: Ucb Pharma, S.a.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Victoria Elizabeth Laing: Innovator in Kinase Inhibitors
Introduction
Victoria Elizabeth Laing is a notable inventor based in Kingston-upon-Thames, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. Her work is essential for advancing treatments for various immune and inflammatory disorders.
Latest Patents
Victoria holds a patent for "Thieno-pyridinone derivatives as kinase inhibitors." This patent describes a series of thieno[2,3-b]pyridin-6(7H)-one derivatives, which are substituted in the 3-position by an arylcarbonyl or heteroaryl-carbonyl moiety. These compounds are recognized for their potential use in medicine, specifically in the treatment and prevention of immune or inflammatory disorders. She has 1 patent to her name.
Career Highlights
Victoria is currently employed at UCB Pharma S.A., where she continues her research and development efforts. Her work at UCB Pharma has positioned her as a key player in the pharmaceutical industry, focusing on innovative solutions for complex medical challenges.
Collaborations
Victoria collaborates with talented colleagues, including Rikki Peter Alexander and Jeremy Martin Davis. Their combined expertise enhances the research environment and fosters innovation within their projects.
Conclusion
Victoria Elizabeth Laing is a pioneering inventor whose work in kinase inhibitors is making a significant impact in the medical field. Her contributions are vital for the advancement of treatments for immune and inflammatory disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile